beta blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study (Q35370417)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	beta blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

8 August 2017

beta blocker treatment and other prognostic variables in patients with clinical evidence of heart failure after acute myocardial infarction: evidence from the AIRE study (English)

1 reference

Europe PubMed Central

8 August 2017

1 reference

based on heuristic

inferred from title

acute myocardial infarction

1 reference

based on heuristic

inferred from title

author name string

Spargias KS

1

1 reference

Europe PubMed Central

8 August 2017

Hall AS

2

1 reference

Europe PubMed Central

8 August 2017

Greenwood DC

3

1 reference

Europe PubMed Central

8 August 2017

Ball SG

4

1 reference

Europe PubMed Central

8 August 2017

language of work or name

0 references

publication date

1 January 1999

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

81

1 reference

Europe PubMed Central

8 August 2017

1

1 reference

Europe PubMed Central

8 August 2017

25-32

1 reference

Europe PubMed Central

8 August 2017

Beta-blocking agents in heart failure. Should they be used and how?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728912

27 July 2018

The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728912

27 July 2018

Short and long term prognosis of acute myocardial infarction since introduction of thrombolysis

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728912

27 July 2018

Statistical aspects of prognostic factor studies in oncology

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728912

27 July 2018

Primary and secondary prevention of myocardial infarction and strokes: an update of randomly allocated, controlled trials.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728912

27 July 2018

Activation of neurohumoral systems in postinfarction left ventricular dysfunction.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728912

27 July 2018

Beta-blockers and sudden cardiac death.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728912

27 July 2018

Rationale for treatment of patients with chronic heart failure with adrenergic blockade

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728912

27 July 2018

Postinfarct risk stratification

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728912

27 July 2018

Positive synergism between diuretics and methylprednisolone following acute myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728912

27 July 2018

Beta blockade during and after myocardial infarction: an overview of the randomized trials

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728912

27 July 2018

Do the results of randomized clinical trials of cardiovascular drugs influence medical practice? The SAVE Investigators

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728912

27 July 2018

The risk of determining risk with multivariable models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728912

26 September 2018

Beta-blockers after myocardial infarction: influence of first-year clinical course on long-term effectiveness.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728912

26 September 2018

Treatment with beta-adrenergic blocking agents after myocardial infarction: from randomized trials to clinical practice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728912

26 September 2018

Influence of heart size on mortality and reinfarction in patients treated with timolol after myocardial infarction

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728912

26 September 2018

Secondary prevention after high-risk acute myocardial infarction with low-dose acebutolol.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=1728912

26 September 2018

Clinical pharmacology of the beta-blocking drugs: implications for the postinfarction patient

1 reference

https://pubmed.ncbi.nlm.nih.gov/10220541

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-blockers and antithrombotics for secondary prevention after myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/10220541

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of propranolol in postinfarction patients with mechanical or electrical complications

1 reference

https://pubmed.ncbi.nlm.nih.gov/10220541

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Effect of propranolol after acute myocardial infarction in patients with congestive heart failure

1 reference

https://pubmed.ncbi.nlm.nih.gov/10220541

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Limitations and advantages of the ejection fraction for defining high risk after acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/10220541

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Influence on prognosis and morbidity of left ventricular ejection fraction with and without signs of left ventricular failure after acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/10220541

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Role of left ventricular dysfunction in selective neurohumoral activation in the recovery phase of anterior wall acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/10220541

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Relation between beta-adrenergic blocker use, various correlates of left ventricular function and the chance of developing congestive heart failure. The Multicenter Diltiazem Post-Infarction Research Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10220541

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Interrelation of left ventricular ejection fraction, pulmonary congestion and outcome in acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/10220541

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beneficial effects of metoprolol in idiopathic dilated cardiomyopathy. Metoprolol in Dilated Cardiomyopathy (MDC) Trial Study Group

1 reference

https://pubmed.ncbi.nlm.nih.gov/10220541

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Beta-blocker therapy in the cardiac arrhythmia suppression trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/10220541

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Predictors of mortality in patients with sustained ventricular tachycardias or ventricular fibrillation and depressed left ventricular function: importance of beta-blockade

1 reference

https://pubmed.ncbi.nlm.nih.gov/10220541

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Cardiologists' practices compared with practice guidelines: use of beta-blockade after acute myocardial infarction

1 reference

https://pubmed.ncbi.nlm.nih.gov/10220541

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Additive beneficial effects of beta-blockers to angiotensin-converting enzyme inhibitors in the Survival and Ventricular Enlargement (SAVE) Study. SAVE Investigators

1 reference

https://pubmed.ncbi.nlm.nih.gov/10220541

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Can beta blockers be safely used in patients with recent myocardial infarction who also have congestive heart failure?

1 reference

https://pubmed.ncbi.nlm.nih.gov/10220541

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1136/HRT.81.1.25

0 references

1 reference

Europe PubMed Central

8 August 2017

1 reference

Europe PubMed Central

8 August 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q35370417&oldid=1577631742"